Form 4 · Filed Jun 3, 2026, 09:36 PM UTC
CRBP/Corbus Pharmaceuticals Holdings, Inc.
Saxena Nishant C — Chief Business Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | P | buy | 9,000 | $8 | $68,220 | 75,300 |
| Jun 2, 2026 | P | buy | 4,500 | $7 | $32,999 | 66,300 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-255834